LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 48

Search options

  1. Article: Staging of lung cancer.

    Milroy, Robert

    Chest

    2008  Volume 133, Issue 3, Page(s) 593–595

    MeSH term(s) Biopsy, Needle ; Bronchoscopy/methods ; Carcinoma, Non-Small-Cell Lung/epidemiology ; Carcinoma, Non-Small-Cell Lung/pathology ; Global Health ; Humans ; Lung Neoplasms/epidemiology ; Lung Neoplasms/pathology ; Morbidity/trends ; Neoplasm Staging/methods ; Retrospective Studies ; Severity of Illness Index ; Tomography, Emission-Computed, Single-Photon/methods ; Tomography, X-Ray Computed/methods
    Language English
    Publishing date 2008-03
    Publishing country United States
    Document type Comment ; Editorial
    ZDB-ID 1032552-9
    ISSN 1931-3543 ; 0012-3692
    ISSN (online) 1931-3543
    ISSN 0012-3692
    DOI 10.1378/chest.07-2638
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: New American College of Chest Physicians lung cancer guidelines: an important addition to the lung cancer guidelines armamentarium.

    Milroy, Robert

    Chest

    2007  Volume 132, Issue 3, Page(s) 744–746

    MeSH term(s) Humans ; Lung Neoplasms/diagnosis ; Lung Neoplasms/epidemiology ; Lung Neoplasms/therapy ; Practice Guidelines as Topic
    Language English
    Publishing date 2007-09
    Publishing country United States
    Document type Editorial
    ZDB-ID 1032552-9
    ISSN 1931-3543 ; 0012-3692
    ISSN (online) 1931-3543
    ISSN 0012-3692
    DOI 10.1378/chest.07-1493
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Lung cancer stigma: A concept with consequences for patients.

    Maguire, Roma / Lewis, Liane / Kotronoulas, Grigorios / McPhelim, John / Milroy, Robert / Cataldo, Janine

    Cancer reports (Hoboken, N.J.)

    2019  Volume 2, Issue 5, Page(s) e1201

    Abstract: Background: Patients with lung cancer (LC) report lower quality of life (QoL) and higher levels of psychological distress compared with other cancer populations. Lung cancer stigma (LCS) may in part explain these findings.: Aim: We investigated the ... ...

    Abstract Background: Patients with lung cancer (LC) report lower quality of life (QoL) and higher levels of psychological distress compared with other cancer populations. Lung cancer stigma (LCS) may in part explain these findings.
    Aim: We investigated the prevalence of patient-perceived lung cancer stigma (LCS) and its relationships to symptom burden/severity, depression, and deficits in health-related quality of life (HR-QoL).
    Methods: In this descriptive, observational, and cross-sectional study, 201 participants were sent questionnaires. These included the Cataldo Lung Cancer Stigma Scale (CLCSS), the Lung Cancer Symptom Scale, the Centre for Epidemiologic Studies-Depression Scale, and the Quality of Life Inventory.
    Results: Participants were on average 69 years old, 52% women, 95% ever smokers, and 18.5% current smokers. The mean total CLCSS score was 53.1 (SD = 14.1; range = 31-94). LCS was significantly correlated with younger age (P < .001), greater social deprivation (P < .05), being unemployed (P < .001), depression (P < .001), symptom burden (P < .001), and HR-QoL deficits (P < .001). Symptom burden explained 18% of variance in LCS (P < .001). LCS explained 8.5% and 14.3% of the variance in depression (P < .001) and HR-QoL (P < .001), respectively.
    Conclusion: Patients with lung cancer are vulnerable to LCS. Symptom burden can directly contribute to greater perceived LCS. Greater perceived LCS can be directly related to greater levels of depression and lower HR-QoL. A tailored approach is required to screen for LCS and implement interventions to enhance the psychosocial well-being of patients with perceived LCS.
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; Cancer Survivors/psychology ; Cross-Sectional Studies ; Depression/diagnosis ; Depression/epidemiology ; Depression/etiology ; Depression/psychology ; Female ; Humans ; Lung Neoplasms/diagnosis ; Lung Neoplasms/psychology ; Male ; Middle Aged ; Psychiatric Status Rating Scales/statistics & numerical data ; Psychological Distress ; Quality of Life ; Scotland ; Severity of Illness Index ; Social Stigma ; Survivorship
    Language English
    Publishing date 2019-06-24
    Publishing country United States
    Document type Journal Article ; Multicenter Study ; Observational Study ; Research Support, Non-U.S. Gov't
    ISSN 2573-8348
    ISSN (online) 2573-8348
    DOI 10.1002/cnr2.1201
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Chronic obstructive pulmonary disease: a complex comorbidity of lung cancer.

    Grose, Derek / Milroy, Robert

    Journal of comorbidity

    2011  Volume 1, Page(s) 45–50

    Abstract: Chronic obstructive pulmonary disease (COPD) is a major burden throughout the world. It is associated with a significantly increased incidence of lung cancer and may influence treatment options and outcome. Impaired lung function confirming COPD is an ... ...

    Abstract Chronic obstructive pulmonary disease (COPD) is a major burden throughout the world. It is associated with a significantly increased incidence of lung cancer and may influence treatment options and outcome. Impaired lung function confirming COPD is an independent risk factor for lung cancer. Oxidative stress and inflammation may be a key link between COPD and lung cancer, with numerous molecular markers being analysed to attempt to understand the pathway of lung cancer development. COPD negatively influences the ability to deliver radical treatment options, so attempts must be made to look for alternative methods of treating lung cancer, while aiming to manage the underlying COPD. Detailed assessment and management plans utilising the multidisciplinary team must be made for all lung cancer patients with COPD to provide the best care possible. Journal of Comorbidity 2011;1:45-50.
    Language English
    Publishing date 2011-12-27
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2831678-2
    ISSN 2235-042X ; 2235-042X
    ISSN (online) 2235-042X
    ISSN 2235-042X
    DOI 10.15256/joc.2011.1.5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Obtaining tissue diagnosis in lung cancer patients with poor performance status and its influence on treatment and survival.

    Maclay, John D / Farley, John M B / McCowan, Colin / Tweed, Conor / Milroy, Robert

    Respiratory medicine

    2017  Volume 124, Page(s) 30–35

    Abstract: Introduction: 25% of patients with lung cancer have performance status 3 or 4. A pragmatic approach to investigative procedures is often adopted based on the risks and benefits in these patients and whether tissue diagnosis is necessary for anticipated ... ...

    Abstract Introduction: 25% of patients with lung cancer have performance status 3 or 4. A pragmatic approach to investigative procedures is often adopted based on the risks and benefits in these patients and whether tissue diagnosis is necessary for anticipated future treatment. This cohort study investigated factors influencing a clinician's decision to pursue a tissue diagnosis in patients with lung cancer and performance status 3 and 4 and to examine the association of tissue diagnosis with subsequent management and survival.
    Methods: All patients with lung cancer diagnosed in North Glasgow from 2009 to 2012 were prospectively recorded in a registry. We investigated the relationships between achieving a tissue diagnosis, treatment and survival.
    Results: Of 2493 patients diagnosed with lung cancer, 490 patients (20%) were PS 3 and 122 patients (5%) were PS 4. Tissue diagnosis was attempted in 60% and 35% patients with PS 3 and PS 4 respectively. Younger age, better performance status and having stage 4 disease were independently associated with a diagnostic procedure being performed. Only 5% of patients with poor performance status received treatment conventionally requiring a tissue diagnosis. Age, stage and performance status were independent predictors of mortality. Achieving a tissue diagnosis was not associated with mortality. Receiving treatment requiring tissue diagnosis is associated with survival benefit.
    Conclusions: The majority of patients with poor fitness undergo a diagnostic procedure which does not influence further treatment or affect survival. However, the cohort of patients who do undergo therapy determined by tissue diagnosis have improved survival.
    Language English
    Publishing date 2017-03
    Publishing country England
    Document type Journal Article
    ZDB-ID 1003348-8
    ISSN 1532-3064 ; 0954-6111
    ISSN (online) 1532-3064
    ISSN 0954-6111
    DOI 10.1016/j.rmed.2017.01.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: ADVANCE-1: An adapted collaborative benchmarking approach in centre-based lung cancer care.

    McCann, Brendan / Muhr, Riccardo / O'Rourke, Noelle / Milroy, Robert / Kollmeier, Jens / Misch, Daniel / van der Horst, Joris / Morrison, David / Bauer, Torsten / Massalski, Oliver / Blum, Torsten Gerriet

    Lung cancer (Amsterdam, Netherlands)

    2020  Volume 151, Page(s) 44–52

    Abstract: The majority of research within lung cancer is focused on prevention, diagnosis and treatment rather than examining infrastructure or processes of lung cancer centres. Benchmarking is a systematic method for documenting and comparing processes, functions ...

    Abstract The majority of research within lung cancer is focused on prevention, diagnosis and treatment rather than examining infrastructure or processes of lung cancer centres. Benchmarking is a systematic method for documenting and comparing processes, functions or performance of organisations against the best in the world. ADVANCE-1 is a European Respiratory Society funded pilot study with the main aim of creating a benchmarking tool that can easily document and reflect the structure and process within a lung cancer centre and its associated registry. By doing this we can then compare centres and generate best practice learning points from each centre in order to learn from each other. The ADVANCE-1 study group was constituted by two ERS fellowship-holders and senior lung cancer specialists from the two participating lung cancer services in Glasgow, Scotland, and Berlin, Germany. The study design and benchmarking tools were reviewed externally. Once the benchmarking tools were created, prospective testing was undertaken in the two participating centres in order to allow comparison to ascertain best practice in a so called 'collaborative benchmarking approach'. We were then able to create personalised learning points for each centre. The next phase of the project will be to expand the benchmarking across several European centres in the ADANCE-2 project.
    MeSH term(s) Benchmarking ; Germany ; Humans ; Lung Neoplasms/diagnosis ; Lung Neoplasms/epidemiology ; Lung Neoplasms/therapy ; Pilot Projects ; Prospective Studies ; Scotland
    Language English
    Publishing date 2020-11-26
    Publishing country Ireland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 632771-0
    ISSN 1872-8332 ; 0169-5002
    ISSN (online) 1872-8332
    ISSN 0169-5002
    DOI 10.1016/j.lungcan.2020.11.019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: European Respiratory Society guideline on various aspects of quality in lung cancer care.

    Blum, Torsten Gerriet / Morgan, Rebecca L / Durieux, Valérie / Chorostowska-Wynimko, Joanna / Baldwin, David R / Boyd, Jeanette / Faivre-Finn, Corinne / Galateau-Salle, Françoise / Gamarra, Fernando / Grigoriu, Bogdan / Hardavella, Georgia / Hauptmann, Michael / Jakobsen, Erik / Jovanovic, Dragana / Knaut, Paul / Massard, Gilbert / McPhelim, John / Meert, Anne-Pascale / Milroy, Robert /
    Muhr, Riccardo / Mutti, Luciano / Paesmans, Marianne / Powell, Pippa / Putora, Paul Martin / Rawlinson, Janette / Rich, Anna L / Rigau, David / de Ruysscher, Dirk / Sculier, Jean-Paul / Schepereel, Arnaud / Subotic, Dragan / Van Schil, Paul / Tonia, Thomy / Williams, Clare / Berghmans, Thierry

    The European respiratory journal

    2023  Volume 61, Issue 2

    Abstract: This European Respiratory Society guideline is dedicated to the provision of good quality recommendations in lung cancer care. All the clinical recommendations contained were based on a comprehensive systematic review and evidence syntheses based on ... ...

    Abstract This European Respiratory Society guideline is dedicated to the provision of good quality recommendations in lung cancer care. All the clinical recommendations contained were based on a comprehensive systematic review and evidence syntheses based on eight PICO (Patients, Intervention, Comparison, Outcomes) questions. The evidence was appraised in compliance with the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach. Evidence profiles and the GRADE Evidence to Decision frameworks were used to summarise results and to make the decision-making process transparent. A multidisciplinary Task Force panel of lung cancer experts formulated and consented the clinical recommendations following thorough discussions of the systematic review results. In particular, we have made recommendations relating to the following quality improvement measures deemed applicable to routine lung cancer care: 1) avoidance of delay in the diagnostic and therapeutic period, 2) integration of multidisciplinary teams and multidisciplinary consultations, 3) implementation of and adherence to lung cancer guidelines, 4) benefit of higher institutional/individual volume and advanced specialisation in lung cancer surgery and other procedures, 5) need for pathological confirmation of lesions in patients with pulmonary lesions and suspected lung cancer, and histological subtyping and molecular characterisation for actionable targets or response to treatment of confirmed lung cancers, 6) added value of early integration of palliative care teams or specialists, 7) advantage of integrating specific quality improvement measures, and 8) benefit of using patient decision tools. These recommendations should be reconsidered and updated, as appropriate, as new evidence becomes available.
    MeSH term(s) Humans ; Lung/pathology ; Lung Neoplasms/diagnosis ; Lung Neoplasms/therapy ; Lung Neoplasms/pathology ; Thorax ; Societies, Medical
    Language English
    Publishing date 2023-02-16
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 639359-7
    ISSN 1399-3003 ; 0903-1936
    ISSN (online) 1399-3003
    ISSN 0903-1936
    DOI 10.1183/13993003.03201-2021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Fighting lung cancer in the developed world--a model of care in a UK hospital.

    Baig, Inam Mohammad / Downer, Penny / Milroy, Robert

    JPMA. The Journal of the Pakistan Medical Association

    2010  Volume 60, Issue 2, Page(s) 93–97

    Abstract: Objectives: To highlight the initial management approach for Lung Cancer in a UK Hospital with the aim of translating the principles of such methodology to a developing country, such as Pakistan.: Methods: A descriptive observational study was ... ...

    Abstract Objectives: To highlight the initial management approach for Lung Cancer in a UK Hospital with the aim of translating the principles of such methodology to a developing country, such as Pakistan.
    Methods: A descriptive observational study was carried out at Stobhill Hospital, Glasgow, UK. The investigator (IMB) observed the Lung Cancer Service, attending the weekly 'New patients Clinic', 'Results Clinic', and 'Multidisciplinary team (MDT) meetings'. The process observations and the factual data describing the details of the service were recorded on a pre-designed pro-forma. Observations relating to two aspects of this service (Results Clinic and MDT) are included in this report.
    Results: The methodology of communicating results of lung cancer investigations to patients in a pre-planned and staged manner at a dedicated 'Results Clinic' was identified as a useful approach. A format of communication was consistently followed.
    Conclusion: The MDT consisted of a Respiratory Physician, Clinical Oncologist, Thoracic Surgeon, Radiologist, Pathologist and Palliative Care Specialist. Each patient's case was discussed on an individual basis and the team developed a consensus regarding diagnosis, staging of the disease, further need for diagnostic procedures and treatment options, bearing in mind the patient's performance status, co-morbidity and their wishes. This approach has improved the initial part of the lung cancer patient journey and components of this approach could easily be transferred to a developing country.
    MeSH term(s) Clinical Protocols ; Humans ; Lung Neoplasms/diagnosis ; Lung Neoplasms/therapy ; Prospective Studies ; United Kingdom
    Language English
    Publishing date 2010-02
    Publishing country Pakistan
    Document type Journal Article
    ZDB-ID 603873-6
    ISSN 0030-9982
    ISSN 0030-9982
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Exploring Inclusion of College Students with IDD in Campus Recreation and Sports Through the Lens of IPSE Programs’ Organizational Level Stakeholders

    Lindsey Ryan Oakes / Tracy R. Nichols, Ph.D. / Stuart J. Schleien, Ph.D., LRT/CTRS, CPRP / Jeffrey J. Milroy, Dr.PH / Robert W. Strack, Ph.D.

    Journal of Inclusive Postsecondary Education, Vol 2, Iss

    2020  Volume 2

    Abstract: Participation in recreation and sports can produce health benefits for all college students and open pathways to inclusion for individuals with intellectual and/or developmental disabilities (IDD). Despite the growing number of college students with IDD ... ...

    Abstract Participation in recreation and sports can produce health benefits for all college students and open pathways to inclusion for individuals with intellectual and/or developmental disabilities (IDD). Despite the growing number of college students with IDD on over 260 college campuses across the United States, there is a dearth of literature exploring their inclusion within campus recreation and sports. This study examined how organizational culture of campus recreation and sports departments and inclusive postsecondary education (IPSE) programs support and inhibit inclusion of college students with IDD, along with placements of IPSE programs on an academic-specific and broader continuum of inclusion.
    Keywords inclusion ; campus recreation and sports ; intellectual and/or developmental disability ; organizational culture ; inclusive postsecondary education programs ; Special aspects of education ; LC8-6691
    Subject code 796
    Language English
    Publishing date 2020-09-01T00:00:00Z
    Publisher Mason Journals
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article ; Online: Chronic Obstructive Pulmonary Disease

    Derek Grose MRCP, FRCR / Robert Milroy

    Journal of Comorbidity, Vol

    A Complex Comorbidity of Lung Cancer

    2011  Volume 1

    Abstract: Chronic obstructive pulmonary disease (COPD) is a major burden throughout the world. It is associated with a significantly increased incidence of lung cancer and may influence treatment options and outcome. Impaired lung function confirming COPD is an ... ...

    Abstract Chronic obstructive pulmonary disease (COPD) is a major burden throughout the world. It is associated with a significantly increased incidence of lung cancer and may influence treatment options and outcome. Impaired lung function confirming COPD is an independent risk factor for lung cancer. Oxidative stress and inflammation may be a key link between COPD and lung cancer, with numerous molecular markers being analysed to attempt to understand the pathway of lung cancer development. COPD negatively influences the ability to deliver radical treatment options, so attempts must be made to look for alternative methods of treating lung cancer, while aiming to manage the underlying COPD. Detailed assessment and management plans utilising the multidisciplinary team must be made for all lung cancer patients with COPD to provide the best care possible.
    Keywords Medicine ; R
    Language English
    Publishing date 2011-01-01T00:00:00Z
    Publisher SAGE Publishing
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top